New NO product reduces diabetic pain

The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.

Samuel Lagercrantz: Collaboration and joint efforts are the key to success

Although many questions about Covid-19 remain unanswered, the development of drugs and vaccines has been incredibly rapid, writes Samuel Lagercrantz, Life Scien...

An industry emerging from crisis

"Scanlab is normally indicative of the status of investment incentives in the laboratory industry "

How to become globally competitive

Here Gunilla Osswald from BioArctic share her experience of scaling up and be competative on the global arena.

Future drugs from Amaryllis

A Danish research team has discovered possibolities to extract drugs fro Amaryllis.

Nya resultat om immunförsvarets reaktion vid svår covid-19

Forskare har identifierat flera celltyper som är centrala vid immunförsvarets reaktion vid covid-19.

Schizophrenia and bipolar disorder are relatives

Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.

Woman deficit in Swedish research

The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.

MVA:s CEO: “Our investments should improve people´s everyday lives”

Involuntary infertility and diabetes are two of the areas on the agenda of the Medicon Valley Alliance.

Medicult acquires embryo scanner

The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.

”Sverige klarar tillverkningen”

I Matfors bygger Cobra Biologics två unika tillverkningssviter för storskalig GMP-tillverkning av ATMP-produkter. Kontraktstillverkaren rustar för att möta den ...

Printing sensors for biological samples

Acreo develops technologies for printed electronics. Using organic printers, Acreo can print a transistor where biological samples can be placed.

Samuel Lagercrantz: Framgången kommer efter många misslyckanden

De allra flesta av de idéer och strategier mot covid-19 som man nu jobbar med kommer att gå i stöpet, men det kan räcka med att en enda fungerar, skriver Samuel Lagercrantz.

We are poor lobbyists

I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.

Astrazeneca varslar i Indien

Stänger site och flyttar forskningen.

Uppsving för Pandemifonden: ”Förut ville ingen lyssna”

Virologiprofessorn Niklas Arnberg pratar om smittspridning, punk och vaccinskepticism med Life Science Sweden, men framförallt om Pandemifonden som ska få Sveri...

Drug development creates new challenges for regulators

LEO Pharma - International Clinical Trial Manager

First ever study of human stem cell treatment

The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.

Forskningsproppen: SwedenBios tredje förslag

Möjliggör för fler företagsinitierade kliniska prövningar - så lyder SwedenBios tredje förslag till regeringen inför forskningsproppen nästa höst.

Bring talent to those in need

Ho ho ho, Christmas time is here again. So get busy decking the halls, perhaps not with assorted greenery, but with something of a more lasting value.

Showroom for free

The latest equipment with trained staff. Sci Life Lab in Stockholm want to offer top conditions at the new imaging laboratory. But some vendors are skeptical to...

Hallå där Mats Nilsson…

…ny site-chef på Scilifelab i Stockholm. Vad ska du göra?

Sobi flyttar tillverkning till Pfizer

Sobi flyttar tillverkning från Österrike till Pfizers anläggning i Strängnäs.